New Clinical Study Highlights the Efficacy of Digexin in Enhancing GI and Mental Health

A comprehensive clinical trial has recently highlighted the significant benefits of Digexin®, a proprietary blend developed by NXT USA, in promoting gastrointestinal and mental wellness. Published in the Journal of the American Nutrition Association, the research sheds light on Digexin's ability to alleviate functional constipation, reduce gastrointestinal transit times, and bolster bowel function through a novel brain-to-gut mechanism.

Freemen Nutra Group, the exclusive distributor of Digexin in the US and Europe, has expressed satisfaction with the trial results, which not only confirm the product's impact on digestive health but also underscore its influence on psychological factors. The trial engaged 135 participants over 60 days, revealing that Digexin significantly outperformed a placebo in easing constipation and improving overall quality of life. The study also highlighted the ingredient's ability to modify the body's stress response, facilitating a shift to a parasympathetic state favoring digestion.

The potential of brain-to-gut communication in addressing gastrointestinal issues alongside secondary psychological symptoms has positioned Digexin as a noteworthy innovation in digestive health solutions.